Your browser doesn't support javascript.
loading
Inhaled silica nanoparticles cause chronic kidney disease in rats.
Sasai, Fumihiko; Rogers, Keegan L; Orlicky, David J; Stem, Arthur; Schaeffer, Joshua; Garcia, Gabriela; Fox, Jacob; Ray, Matthew S; Butler-Dawson, Jaime; Gonzalez-Quiroz, Marvin; Leiva, Ricardo; Taduri, Gangadhar; Anutrakululchai, Sirirat; Venugopal, Vidhya; Madero, Magdalena; Glaser, Jason; Wijkstrom, Julia; Wernerson, Annika; Brown, Jared M; Johnson, Richard J; Roncal-Jimenez, Carlos A.
Afiliação
  • Sasai F; Division of Renal Disease, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Rogers KL; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Orlicky DJ; Department of Pathology, University of Colorado School of Medicine, Aurora, Colorado.
  • Stem A; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Schaeffer J; Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado.
  • Garcia G; Center for Health, Work & Environment, Department of Environmental and Occupational Health, Colorado School of Public Health, University of Colorado, Aurora, Colorado.
  • Fox J; Division of Renal Disease, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Ray MS; Division of Renal Disease, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Butler-Dawson J; Division of Renal Disease, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Gonzalez-Quiroz M; Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado.
  • Leiva R; Centre for Nephrology, University College London, London, United Kingdom.
  • Taduri G; Division of Kidney Diseases, Hospital Rosales, San Salvador, El Salvador.
  • Anutrakululchai S; Division of Nephrology, Nizams Institute of Medical Sciences, Hyderabad, India.
  • Venugopal V; Division of Kidney Diseases, Khon Kaen University, Khon Kaen, Thailand.
  • Madero M; School of Public Health, Sri Ramachandra Medical College and Research Institute, Chennai, India.
  • Glaser J; Division of Kidney Diseases, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Wijkstrom J; La Isla Network, Washington, District of Columbia.
  • Wernerson A; Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.
  • Brown JM; Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.
  • Johnson RJ; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Roncal-Jimenez CA; Division of Renal Disease, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Am J Physiol Renal Physiol ; 323(1): F48-F58, 2022 07 01.
Article em En | MEDLINE | ID: mdl-35635324
ABSTRACT
Silica nanoparticles (SiNPs) released during the burning of sugarcane have been postulated to have a role in chronic kidney disease of unknown etiology. We tested the hypothesis that pristine SiNPs of the size present in sugarcane might cause chronic kidney injury when administered through the lung in rats. We administered 200- or 300-nm amorphous SiNPs twice weekly (4 mg/dose), or vehicle by oropharyngeal aspiration for 13 wk to rats followed by euthanasia after an additional 13 wk (26 wk total). Tissues were evaluated for the presence of SiNPs and evidence of histological injury. Both sizes of SiNPs caused kidney damage, with early tubular injury and inflammation (at week 13) that continued to inflammation and chronic fibrosis at week 26 despite discontinuation of the SiNP administration. Both sizes of SiNPs caused local inflammation in the lung and kidney and were detected in the serum and urine at week 13, and the 200-nm particles were also localized to the kidney with no evidence of retention of the 300-nm particles. At week 26, there was some clearance of the 200-nm silica from the kidneys, and urinary levels of SiNPs were reduced but still significant in both 200- and 300 nm-exposed rats. In conclusion, inhaled SiNPs cause chronic kidney injury that progresses despite stopping the SiNP administration. These findings support the hypothesis that human exposure to amorphous silica nanoparticles found in burned sugarcane fields could have a participatory role in chronic kidney disease of unknown etiology.NEW & NOTEWORTHY Inhalation of silica nanoparticles (SiNPs) released during the burning of sugarcane has been postulated to have a role in chronic kidney disease of unknown etiology (CKDu). We administered 200- and 300-nm amorphous SiNPs to rats by aspiration and observed kidney damage with tubular injury and inflammation that persisted even after stopping the SiNP exposure. These findings support the hypothesis that human exposure to SiNPs found in sugarcane ash could have a participatory role CKDu.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Nanopartículas Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Nanopartículas Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article